DIAGNOS to Extend Stock Warrants Exercise Period

Core Points - Diagnos Inc. intends to extend the exercise period of 650,000 stock warrants to August 5, 2026, from the original expiry date of September 22, 2025 [1][2] - A correction was made regarding the expiry date of 1,414,286 warrants, which will also be extended to August 5, 2026, instead of February 27, 2029 [3] - The exercise price of the warrants remains unchanged at $0.40 per common share during the extended period [2] Company Overview - Diagnos Inc. is a Canadian corporation focused on the early detection of critical eye-related health issues using Artificial Intelligence [5] - The company aims to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes globally [5]